Study for new biomarker development for diagnosis and evaluation of disease activity in juvenile rheumatic disease

Study for new biomarker development for diagnosis and evaluation of disease activity in juvenile rheumatic disease - Biomarker for juvenile rheumatic disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014119

Enrollment

100

Registered

2014-06-09

Start date

2014-10-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

juvenile idiopathic arthritis, juvenile systemic erythematosus, juvenile dermatomyositis, juvenile Sjoegren syndrome, juvenile connective tissue disease, Henoch-Schonlein purpura, juvenile polyarteritis nodosa, juvenile aortitis syndrome, ulcerative colitis, Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pediatric rheumatic disease patients

Exclusion criteria

Exclusion criteria: patient who did not fulfill the rheumatic disease criteria. patients for whom data were insufficient.

Design outcomes

Primary

Measure	Time frame
to establish significant parameters that help to distinguish remission from flare of diseases, and identify cut off values	—

Secondary

Measure	Time frame
PTX3 versus C-reactive protein PTX3 versus sLOX-1 PTX3 versus disease activity sLOX-1 versus disease activity PTX3 with steroid dose PTX3 with hospitalization	—

Countries

Japan

Contacts

Public ContactToshiyuki Kitoh

Aichi Medical University Pediatrics

tkitoh@aichi-med-u.ac.jp+81561623311

Outcome results